The first Bluebird bio trade was made in Q4 2016.
Since then Cathie Wood bought shares six more times and sold shares on four occasions. The investor completely sold their stake between Q4 2018 and Q4 2019.
Avg closing price
Price range
Sold -7.78 Thousand shares
Q4 2019
Avg closing price
$1,086.50
Price range
$938.66
-
$1,232.81
Sold 21.0% shares (-2.07 Thousand shares)
Q1 2019
Avg closing price
$1,760.02
Price range
$1,288.23
-
$2,081.10
Sold 50.8% shares (-10.2 Thousand shares)
Q4 2018
Avg closing price
$1,533.14
Price range
$1,181.41
-
$1,864.37
Increased shares by 52.1% (+6.87 Thousand shares)
Q3 2018
Avg closing price
$2,064.86
Price range
$1,776.33
-
$2,348.59
Increased shares by 33.4% (+3.3 Thousand shares)
Q2 2018
Avg closing price
$2,278.21
Price range
$1,991.90
-
$2,550.56
Increased shares by 62.5% (+3.8 Thousand shares)
Q1 2018
Avg closing price
$2,542.29
Price range
$2,114.89
-
$3,017.30
Sold 9.7% shares (-652 shares)
Q4 2017
Avg closing price
$2,029.15
Price range
$1,624.20
-
$2,612.70
Increased shares by 12.4% (+742 shares)
Q3 2017
Avg closing price
$1,396.42
Price range
$1,154.23
-
$1,827.47
Increased shares by 44.8% (+1.85 Thousand shares)
Q2 2017